Grand View Research Collaborates With Cannyx Markets, To Deliver World-class Cannabinoid Industry Intelligence Platform


Ryan Allway

October 27th, 2020

News, Top News


 Grand View Research, a leading US-based market research provider and Cannyx Corporation Ltd, owner of Cannyx Markets an online real-time trading venue and market data service platform for organic and non-GMO certified hemp and non-medicinal based cannabinoids, have announced a collaboration that will create a world-class Cannabinoid Intelligence Platform, providing unprecedented access to real-time data, market intelligence, and analysis covering all aspects of the industry.

  • Collaboration will see Grand View Research become the official knowledge partner for Cannyx Markets’ cannabinoid real-time trading venue and market data service platform
  • The collaboration will deliver a cutting-edge knowledge and business intelligence platform
  • The result being a world-class Cannabinoid Intelligence Platform providing fully-integrated access to deep sector-specific intelligence, nuanced market reports and forecasts, exclusive analysis, and real-time news.

The collaboration will see Grand View Research become the official knowledge partner for the Cannyx Markets platform, providing users with access to one of the most comprehensive libraries of cannabinoid market datasets, analysis and industry reports, currently available.

Given the highly regulated nature of the cannabinoid industry, along with the growing global implications of operating within the sector, the ability to access accurate, up-to-date market intelligence and data is rapidly becoming a critical factor for market participants.

The collaboration will deliver a cutting-edge knowledge and business intelligence platform combining data from Grand View Research’s extensive library of cannabinoid industry market intelligence with Cannyx Markets trading platform, which provides users with access to the best cannabinoid commodities execution performance metrics currently available. The result being a world-class Cannabinoid Intelligence Platform providing fully-integrated access to deep sector-specific intelligence, nuanced market reports and forecasts, exclusive analysis, and real-time news.

As a gold standard Market platform, Cannyx Markets is designed to deliver the highest professional trading standards and strict oversight into market surveillance, intelligence, compliance, and risk management and, at the same time, meet all regulatory and ethical standards. Users benefit from professional tools that help manage; price risks, compliance, supply chain resilience, and improve the marketing of physical products to a global buyer community.

Globally renowned, Grand View Research is a highly trusted provider of market research, with a market-leading library of reports covering the global cannabinoid industry that is relied upon by companies and organisations around the word.

The company’s Grand View Compass is a best-in-class market research database designed to help business leaders navigate dynamic and uncharted territory. Trusted by the world’s premiere academic institutions and companies, Compass is a flexible, business intelligence dashboard that provides real-time news updates, economic and market forecasts, and access to customized reports that can be configured to aid in any style of analysis and strategic planning.

Swayam Dash, MD & Co-Founder of Grand View Research, says, “We are excited about this partnership. Cannyx’s business model is unique and is designed to deliver indispensable insights to all stakeholders in the Cannabis industry. The future of this industry is promising, and with rapidly intensifying competition, access to market & trading data is imperative.”

“The timing of this collaboration is perfect. Countries are now opening their markets and legalizing cannabis products, and this has created an immense amount of opportunities for investors, producers & distributors. The market is nascent and does not have a centralized knowledge platform. I am optimistic that our platform will provide vital support to industry participants.”

“We are thrilled to be partnering with such a renowned knowledge partner,” comments Mahesh Jayanarayan, CEO & Founder of Cannyx Markets. “The combination of our real-time cannabinoid commodities transaction data alongside Grand View Research’s respected market analytics provides an extremely powerful offering for users of our Cannyx Markets platform.”

“Accurate and relevant market intelligence is critical for anyone looking to achieve a competitive edge in the rapidly expanding cannabinoid industry and through this partnership we are building Cannyx Markets into the number-one intelligence solution, that will provide our users with unparalleled insights into the nuances of this dynamic industry.”

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

More information at www.grandviewresearch.com

About Cannyx Corporation Ltd

Cannyx Corporation Ltd operates Cannyx Markets an online real-time trading venue and Market data service platform which provides real time pricing, global market data and analytics in Organic and non-GMO certified Hemp and Non-Medicinal based Cannabinoids. Cannyx Markets participants can trade securely, underpinned by cutting edge Track & Trace and blockchain technology.

At the heart of the Cannyx Markets is the collective strength of knowledge and expertise of its founders.

Their Banking, brokerage, commodity trading, MTF and business and enterprise technology experience together with years of running private and public companies with astute and uncompromising business acumen. Every one of them has had work experience in some of the top tier institutions in the world.

More information at https://cannyxmarkets.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading